This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kemper, A. J. Articles by Parisi, A. F. Search for Related Content PubMed PubMed Citation Articles by Kemper, A. J. Articles by Parisi, A. F.

Circulation, Vol 70, 309-317, Copyright © 1984 by American Heart Association

ARTICLES

Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion

AJ Kemper, JE O'Boyle, CA Cohen, A Taylor and AF Parisi

During sustained coronary occlusion in canine preparations, the extent of regions that fail to show contrast enhancement when imaged by supra- aortic hydrogen peroxide contrast echocardiography (SHPCE) has been shown to correlate well for single cross sections with the extent of malperfused myocardium "at risk" of infarction. In the present study, SHPCE was investigated as a means of determining the fraction of total left ventricular mass at risk during occlusion. Since necrotic tissue has low blood flow even when reperfused, we also investigated the potential of quantitating the extent of infarcted myocardium by measuring the extent of contrast defects seen with SHPCE performed during reperfusion. In 20 dogs the fraction of the left ventricle showing a contrast defect during coronary occlusion correlated well with the fraction of the left ventricular mass "at risk" by an autoradiographic technique (autoradiography = 0.83 echocardiography + 8.6%; r = .89, SEE = 4.5%). SHPCE was also performed after 3 hr of reperfusion following occlusions varying in duration from 60 to 150 min. The fraction of the ventricle showing a contrast defect during reperfusion predicted the infarcted portion of the left ventricle as shown by triphenyl tetrazolium chloride staining (% left ventricle infarcted = 0.81 echocardiography + 3.3%; r = .84, SEE = 5.3%). Observer variability for the fraction of the ventricle showing a contrast defect was excellent during both occlusion and reperfusion. The ratio of the left ventricular extent of contrast-negative regions during reperfusion and occlusion was used to calculate a necrosis-to- risk index in vivo that correlated relatively well with the myocardial necrosis-to-risk ratio determined morphologically (r = .77, SEE = 16%).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. Kaul Myocardial Contrast Echocardiography: A 25-Year Retrospective Circulation, July 15, 2008; 118(3): 291 - 308. [Full Text] [PDF]

				M. P. Coggins, J. Sklenar, D. E. Le, K. Wei, J. R. Lindner, and S. Kaul Noninvasive Prediction of Ultimate Infarct Size at the Time of Acute Coronary Occlusion Based on the Extent and Magnitude of Collateral-Derived Myocardial Blood Flow Circulation, November 13, 2001; 104(20): 2471 - 2477. [Abstract] [Full Text] [PDF]

				U. Sechtem Imaging myocardial area at risk and final infarct size Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C36 - C46. [PDF]

				S. KAUL Myocardial contrast echocardiography in acute myocardial infarction: time to test for routine clinical use? Heart, January 1, 1999; 81(1): 2 - 5. [Full Text]

				S. F. Nagueh, N. M. Lakkis, Z.-X. He, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, R. Roberts, M. S. Verani, N. S. Kleiman, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., July 1, 1998; 32(1): 225 - 229. [Abstract] [Full Text] [PDF]

				S. Kaul Myocardial Contrast Echocardiography : 15 Years of Research and Development Circulation, November 18, 1997; 96(10): 3745 - 3760. [Full Text]

				S. Aronson Myocardial Contrast Echocardiography: Is it Ready to be Used as a Clinical Tool in the Operating Room? Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1997; 1(1): 4 - 15. [PDF]

				J. Sklenar, G. Camarano, N. C. Goodman, S. Ismail, A. R. Jayaweera, and S. Kaul Contractile Versus Microvascular Reserve for the Determination of the Extent of Myocardial Salvage After Reperfusion: The Effect of Residual Coronary Stenosis Circulation, September 15, 1996; 94(6): 1430 - 1440. [Abstract] [Full Text]

				F. S. Villanueva, G. Camarano, S. Ismail, N. C. Goodman, J. Sklenar, and S. Kaul Coronary Reserve Abnormalities in the Infarcted Myocardium: Assessment of Myocardial Viability Immediately Versus Late After Reflow by Contrast Echocardiography Circulation, August 15, 1996; 94(4): 748 - 754. [Abstract] [Full Text]

				R. S. MELTZER, C. A. VISSER, and V. FUSTER Intracardiac Thrombi and Systemic Embolization Ann Intern Med, May 1, 1986; 104(5): 689 - 698. [Abstract] [PDF]

				K. Kaplan Prophylactic Anticoagulation Following Acute Myocardial Infarction Arch Intern Med, March 1, 1986; 146(3): 593 - 597. [Abstract] [PDF]